The invention relates to methods for treating hypercholesterolemia and atherosclerosis, and reducing serum cholesterol in a mammal. The methods of the invention comprise administering to a mammal a first amount of a bile acid sequestrant compound which is an unsubstituted polydiallylamine polymer and a second amount of a cholesterol-lowering agent. The first and second amounts together comprise a therapeutically effective amount.
The invention further relates to pharmaceutical compositions useful for the treatment of hypercholesterolemia and atherosclerosis, and for reducing serum cholesterol. The pharmaceutical compositions comprise a combination of a first amount of an unsubstituted polydiallylamine polymer compound and a second amount of a cholesterol-lowering agent. The first and second amounts comprise a therapeutically effective amount. The pharmaceutical compositions of the present invention may optionally contain a pharmaceutically acceptable carrier.
本发明涉及治疗高
胆固醇血症和动脉粥样硬化以及降低哺乳动物血清
胆固醇的方法。本发明的方法包括向哺乳动物施用第一种量的
胆汁酸螯合剂化合物(一种未取代的聚
二烯丙基胺聚合物)和第二种量的降
胆固醇剂。第一种和第二种剂量共同构成治疗有效量。
本发明进一步涉及用于治疗高
胆固醇血症和动脉粥样硬化以及降低血清
胆固醇的药物组合物。这些药物组合物由第一种量的未取代聚
二烯丙基胺聚合物化合物和第二种量的降
胆固醇剂组合而成。第一种和第二种剂量均为治疗有效量。本发明的药物组合物可选择含有药学上可接受的载体。